This Issue Brief reviews the current status and characteristics of prescription drug monitoring programs (PDMPs), their use, and evidence of their effectiveness. It summarizes best practices for PDMPs and the needs for further research and evaluation.
This brief summarizes a new systematic review of economic evaluations of treatments for substance use disorders. The review reveals strong evidence that methadone maintenance therapy is an economically advantageous form of treatment; the economic evidence for buprenorphine and naltrexone treatments is more limited.
In the U.S., the use of opioid pain relievers during pregnancy continues to rise. This has contributed to an increased incidence of neonatal abstinence syndrome (NAS), which occurs in approximately 6 per 1000 hospital births and results in long hospital stays and high healthcare costs. While oral morphine is the predominant agent used to treat NAS, in adults, buprenorphine produces less cardiopulmonary depression compared to other long-acting opioids.
Despite provisions in the Affordable Care Act meant to reduce insurance coverage disparities for people with mental health issues, access to healthcare services have deteriorated for those reporting severe distress, according to a new study.
A 1-page distillation of information and statistics about the opioid epidemic and Medicaid’s role in covering addiction treatment services from the Kaiser Family Foundation.
This piece summarizes the mounting evidence which suggests that screening, brief intervention, and referral-to-treatment (SBIRT) alone is ineffective in reducing drug use in primary care - but it is unknown whether the referral-to-treatment (RT) component might increase receipt of formal addiction treatment.
The Thomas Scattergood Behavioral Health Foundation and the Margaret Clark Morgan Foundation believe that now more than ever philanthropic support in the area of policy is critical to improving the health outcomes for all. The two foundations have commissioned a series of six papers that address ways to continue and protect the recent progress of behavioral health policy.
The first in the series is Behavioral Health and the Individual Health Insurance Market: Preserving Key Elements of Reform by Richard Frank, Ph.D. and Sherry Glied, Ph.D., M.A.
There is a pressing need for new strategies to reinvigorate primary care. HNHC populations are among those most likely to benefit from such reforms. Indeed, without better strategies for managing resource-intensive patients, these time-consuming patients may stymie more general efforts to redesign primary care for the twenty-first century.
Over the last 2 decades, medical providers have increasingly prescribed pharmaceutical opioids for chronic non-cancer pain, while opioid overdose death rates have quadrupled. Naloxone, an opioid antagonist, can be prescribed to patients with chronic pain to reverse an opioid overdose, yet little is known about how patients perceive this emerging practice. This study concludes that to improve the naloxone prescribing acceptability in primary care practice, medical providers and health systems may need to enhance patient education, employ empowering, non-judgmental communication styles and adequately frame discussions about naloxone to address patients’ fears.
Collaborative care for depression is more effective in improving treatment outcomes than primary care physicians’ (PCPs) usual care (UC). However, few trials of collaborative care have targeted anxiety. This study concludes that telephone-delivered, centralized, stepped CC improves mental HRQoL, anxiety and mood symptoms. These improvements were durable and particularly evident among those most anxious at baseline, and among African-Americans and men.